Hamamatsu University Hospital Internal Medicine 2
Assistant Professor
井上 裕介
INOUE Yusuke

Last updated: 2025/05/17
Basic information on teaching staff
Career
2005/4/1- 2006/5/31 浜松医科大学附属病院
2006/6/1- 2010/3/31 市立島田市民病院
2010/4/1- 2012/5/31 総合病院聖隷三方原病院
2016/4/1- 2017/3/31 浜松医科大学附属病院
2017/4/1- 2017/8/31 独立行政法人国立病院機構天竜病院
2017/9/1- 2020/8/31 BC Cancer Agency
2020/9/1- 2021/3/31 浜松医科大学
2021/4/1- 2022/3/31 浜松医科大学
2022/4/1- 浜松医科大学
Academic background
2005/3/31 graduated 神戸大学 医学部 医学科
2017/3/31 graduated 浜松医科大学 医学系研究科
Research Areas
Life Science - Respiratory medicine
Research keywords
肺がん
Subject of research
[1]. A prospective observational study to assess the utility of comprehensive genomic profiling in patients with non-small cell lung cancer without driver genetic alterations
[2]. 運命制御転写因子の相互排他的な発現メカニズムに立脚した小細胞肺がんの新規治療戦略の探索
[3]. 細胞形質分化プログラムの破綻を機序とする小細胞肺がんの新規治療戦略の確立
Research activities
Papers
[1]. Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer.
eLife [Volume]10 (2021/) [Reviewed] Yes [DOI]
[2]. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Journal of cancer research and clinical oncology (2022/) [Reviewed] Yes [DOI]
[3]. MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.
NPJ precision oncology [Volume]6 [Issue]1 [Page]88 (2022/) [Reviewed] Yes [DOI]
[4]. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
Cancer immunology, immunotherapy : CII (2023/) [Reviewed] Yes [DOI]
[5]. Longitudinal Assessment of Real-World Treatments and Outcomes in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Prospective, Observational Study
European Journal of Respiratory Medicine (2024/) [Reviewed] Yes
Research presentations
[1]. 2022/11/ EGFRL858R変異遺伝子検出におけるddPCR法と比較したNOIR-SSの有用性 肺癌
[2]. 2022/11/ 非小細胞肺癌患者における血清免疫調整因子とアテゾリズマブ治療による免疫関連有害事象との関連 肺癌
[3]. 2022/11/ 小細胞肺癌の細胞分化に関わる転写因子の肺大細胞神経内分泌癌における意義 肺癌
[4]. 2022/11/ 非小細胞肺癌におけるGeriatric Nutritional Risk Indexとプラチナ併用化学療法の有効性の関連 肺癌
[5]. 2022/10/ サルコイドーシスにおける血清長鎖脂肪酸と多臓器病変の関連 日本サルコイドーシス/肉芽腫性疾患学会雑誌
Prizes
[1]. 2019/1/ BREATHE the lung association National Grant Review/Grant-in-Aid
[2]. 2018/9/1 Michael Smith Foundation for Health Research (MSFHR) Research Trainee Award
[3]. 2017/6/ 浜松医科大学同窓会賞
[4]. 2017/4/ 第7回リリー・オンコロジー・フェローシップ・プログラム
Memberships of academic societies
[1]. 日本サルコイドーシス/肉芽腫性疾患学会
[2]. 日本アレルギー学会
[3]. 日本臨床腫瘍学会
[4]. 日本肺癌学会
[5]. 日本呼吸器学会
Educational activities
Allotted class
[1]. 呼吸器内科学
Social activities
Social Contribution
[1]. 2022/11/6- 複雑化する肺癌薬物療法の Up to Date